In ALK+ ALCL, however, impaired DNA repair pathways (48), particularly DNA mismatch repair, may represent a mechanism by which tumor cells initiate additional genetic lesions, considering that a subset of ALK+ALCL patients develop resistance against ALK-specific treatment approaches. The gene discussed is ALK; the disease is neoplasm.